To Study Vitamin D, Uric acid along with C-REACTIVE Protein in patients of psoriasis in tertiary care hospital in Bihar
DOI:
https://doi.org/10.51168/sjhrafrica.v6i9.2126Keywords:
Psoriasis, Vitamin D, Uric Acid, C-reactive Protein, Systemic Inflammation, BiharAbstract
BackgroundPsoriasis, a persistent severe skin disorder mediated by the immune system, affects two to three percent of individuals globally and is becoming recognized as a systemic disease. Emerging evidence suggests that vitamin D deficiency, hyperuricemia, and elevated C-reactive protein (CRP) may contribute to its pathogenesis and associated comorbidities. Despite India’s high prevalence of vitamin D deficiency, studies exploring the interplay of these biomarkers in psoriasis are limited.
MethodologyA prospective case-control study was conducted in IGIMS, Patna. from February 2020 to October 2021. Out of the 150 participants, 75 had chronic plaque psoriasis and the remaining 75 were healthy controls who were assigned for sex and age. Serum 25-hydroxyvitamin D [25(OH)D], uric acid, along with CRP was measured by chemiluminescent microparticle immunoassay, uricase–peroxidase enzymatic method, and latex-enhanced turbidimetric immunoassay, respectively. The statistical analyses included the t-test, the chi-square test, and Pearson's correlation; a p-value of less than 0.05 was taken to be significant.
ResultsPsoriasis patients showed markedly reduced serum vitamin D levels compared to healthy controls. In contrast, the patient group's levels of uric acid and C-reactive protein (CRP) were noticeably higher. All individuals with psoriasis were vitamin D deficient, and nearly half had elevated CRP levels. Vitamin D demonstrated a strong inverse relationship with CRP and a moderate negative association with uric acid, while CRP positively correlated with uric acid.
Conclusion
Vitamin D deficiency is significantly linked to psoriasis, systemic inflammation, and hyperuricemia, reflecting its systemic nature rather than a skin-limited disorder.
Recommendation Routine screening of vitamin D, CRP, and uric acid levels should be integrated into psoriasis management, particularly in regions with endemic vitamin D deficiency. Vitamin D supplementation and metabolic risk monitoring may improve clinical outcomes and reduce long-term comorbidities. Further longitudinal and interventional studies are warranted to establish causality and therapeutic benefits.References
Boehncke WH, Schön MP. Psoriasis. Lancet. 2015;386(9997):983–94.
Lowes MA, Suárez-Fariñas M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol. 2014;32:227–55.
Takeshita J, Grewal S, Langan SM, et al. Psoriasis and comorbid diseases. J Am Acad Dermatol. 2017;76(3):377–90.
Dogra S, Yadav S. Psoriasis in India: prevalence and pattern. Indian J Dermatol Venereol Leprol. 2010;76(6):595–601.
Prietl B, Treiber G, Pieber TR, Amrein K. Vitamin D and immune function. Nutrients. 2013;5(7):2502–21.
Gisondi P, Rossini M, Di Cesare A, et al. Vitamin D status in chronic plaque psoriasis: a case-control study. Br J Dermatol. 2012;166(3):505–10.
Orgaz-Molina J, Buendía-Eisman A, Arrabal-Polo MA, et al. Deficiency of serum 25-hydroxyvitamin D in psoriatic patients: a case-control study. J Am Acad Dermatol. 2012;67(5):931–8.
Ni C, Yang P, Li Q. Association of psoriatic severity with serum vitamin D3 levels and vitamin D receptor gene polymorphism: an observational study. Medicine (Baltimore). 2020;99(14):e19581.
Aparna P, Muthathal S, Nongkynrih B, Gupta SK. Vitamin D deficiency in India. J Family Med Prim Care. 2018;7(2):324–30.
Chi CC, Wang SH, Chen YF, et al. Serum uric acid and risk of psoriasis: a systematic review and meta-analysis. J Dermatol Sci. 2015;79(1):55–60.
Upala S, Jaruvongvanich V, Wijarnpreecha K. High serum uric acid levels are associated with increased risk of psoriasis: a systematic review and meta-analysis. J Dermatol Treat. 2016;27(5):488–92.
Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis. J Am Heart Assoc. 2013;2(2):e000062.
Gisondi P, Del Giglio M, Girolomoni G. Plasma C-reactive protein concentrations in patients with chronic plaque psoriasis. Br J Dermatol. 2007;156(6):1164–9.
Coto-Segura P, Buendía-Eisman A, Ruiz-Carrascosa JC, et al. C-reactive protein levels in psoriatic patients: relation with severity and clinical outcomes. Actas Dermosifiliogr. 2014;105(7):673–80.
Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 2010;10(4):482–96.
Coimbra S, Oliveira H, Reis F, Belo L, Rocha S, Quintanilha A, et al. C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy. J Eur Acad Dermatol Venereol. 2010;24(7):789–96.
Mehta NN, Yu Y, Pinnelas R, Krishnamoorthy P, Shin DB, Troxel AB, et al. Attributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med. 2011;124(8):775.e1–6.
Rocha-Pereira P, Santos-Silva A, Rebelo I, Figueiredo A, Quintanilha A, Teixeira F. Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clin Chim Acta. 2001;303(1–2):33–9.
Gisondi P, Targher G, Cazzaniga S, Chiarelli S, Girolomoni G. Uric acid levels in patients with chronic plaque psoriasis. J Am Acad Dermatol. 2014;70(6):1278–82.
Kanbay M, Yilmaz MI, Sonmez A, Solak Y, Saglam M, Cakir E, et al. Serum uric acid independently predicts cardiovascular events in advanced nephropathy. Am J Nephrol. 2012;36(4):324–31.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Rajeev Kumar, Parmanand Raju, Pawan Pratap Singh, Rajesh Sinha, Rekha Kumari
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
